Clinical Trial Update: REGEND001 Autologous Basal Layer Stem Cell Transplantation for Bronchiectasis: A Translational Application Study [Phase 1]

View source ↗

Summary

Phase 1 translational study evaluating REGEND001 autologous basal layer stem cell transplantation for bronchiectasis; currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiectasis

Drugs mentioned

• REGEND001 Autologous Basal Layer Stem Cell Transplantation

Snippet

Sponsor: Ruijin Hospital | Conditions: Bronchiectasis Adult | Phase 1 | Status: NOT_YET_RECRUITING